ask="N/A"
ask_size="N/A"
average_daily_volume="43224"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+0.08"
change_from_200_day_moving_average="-0.86"
change_from_50_day_moving_average="-0.93"
change_from_52_week_high="-38.36"
change_From_52_week_low="0.63"
change_in_percent="+1.20%"
close="6.72"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="0.00"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="N/A"
high="6.84"
high_52_weeks="45.08"
last_trade_date="1/5/2017"
last_trade_price="6.72"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.62"
low_52_weeks="6.09"
market_capitalization="66.70B"
moving_average_200_day="7.58"
moving_average_50_day="7.65"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="6.65"
pe_ratio="0.91"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.36%"
percent_change_from_50_day_moving_average="-12.17%"
percent_change_from_52_week_high="-85.09%"
percent_change_from_52_week_low="+10.34%"
previous_close="6.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9925000000"
short_ratio="0.00"
stock_exchange="NGM"
symbol="KALV"
volume="33861"
weeks_range_52="6.09 - 45.08"
